Using quantitative image analysis, we evaluated the MIB-1 labeling index (L
I) in a large population of pilocytic (n = 131) and diffuse astrocytomas (n
= 140), explored its significance as a prognostic predictor of survival, a
nd compared it to other commonly accepted predictors, including grade and i
ts histologic determinants, atypia, mitoses, endothelial proliferation, and
necrosis. Diffuse astrocytomas were graded according to the St Anne-Mayo s
cheme and included 45 grade 2, 50 grade 3, and 45 grade 4 astrocytomas. In
pilocytic astrocytomas, mean, median, and range of MIB-1 LIs were 1.1, 0.9,
and 0-3.9%, respectively. In diffuse astrocytomas, these values were 2.3,
2, and 0-7.6% in grade 2; 6, 4.4, and 0.1-25.7% in grade 3; 9.1, 6, and 0.3
-36% in grade 4. There was a significant difference in the distribution of
MIB-1 LIs between pilocytic and diffuse grade 2 astrocytomas (p < 0.001), b
etween grade 2 and grade 3 (p < 0.001), and between tumors of grade 3 and 4
(p = 0.014). Among pilocytic astrocytomas there was no association between
survival and MIB-1 LI or any histologic parameter. Ln diffuse astrocytomas
, MLB-1 LI was significantly correlated with grade as well as with mitotic
activity (<0.001) and survival. While in diffuse astrocytomas of all grades
, necrosis was the strongest factor associated with survival, in tumors of
grades 2 and 3 the MIB-1 LI preceded other histologic parameters and, on mu
ltivariate analysis, remained the only feature predictive of survival. Grad
e 3 astrocytomas with a single "solitary" mitosis had a significantly lower
MIB-1 LI than did grade 3 tumors with >1 mitosis and, compared to the latt
er, had a significantly longer survival (p = 0.013), one not significantly
different from patients with grade 2 astrocytomas. These findings suggest t
hat the cutoff point between grade 2 and 3 in the St. Anne-Mayo scheme may
not be optimal and may need to be revised.